DIOVAN

This brand name is authorized in Nigeria. It is also authorized in Albania, Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, Germany, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK, United States.

Active ingredients

The drug DIOVAN contains one active pharmaceutical ingredient (API):

1	Valsartan UNII 80M03YXJ7I - VALSARTAN
	Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II.
	Read more about Valsartan

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-2100	Tablet	Diovan 80 mg Tablets TAB 80 mg	Film-coated tablet (FCT)	21/12/2020
A4-0017	Tablet	Diovan 160 mg TAB 160 mg 2 x 14's (in blisters)	Film-coated tablet (FCT)	28/01/2021
B4-2584	Tablet	Diovan 320 mg Tablets TAB 320 mg	Film-coated tablet (FCT)	25/02/2021

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DIOVAN Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA03	Valsartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	388/92
AU	Pharmaceutical Benefits Scheme	9368C, 9369D, 9370E, 9371F
BR	Câmara de Regulação do Mercado de Medicamentos	526504803110310, 526504804117319, 526504807116313, 526504809119212, 526504811113315, 526504812111316
CA	Health Products and Food Branch	02244781, 02244782, 02270528, 02289504
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01499579, 01878472, 01878555, 02428995, 04948463, 04948492, 09236193, 09484956, 10086907, 10116407, 10177308, 10851590, 10916013, 10979019, 13577706, 14018469, 14018475, 14277343, 14277372, 15735055, 15735061, 17874105
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29558-01-11, 29559-01-11, H7381013
EE	Ravimiamet	1013285, 1013296, 1092844, 1092855, 1092866, 1092877, 1092888, 1092899, 1149634, 1149645, 1198650, 1198672, 1198683, 1198694, 1198706, 1198717, 1303311, 1303322, 1473601, 1512122, 1512133, 1512144, 1512155, 1512256, 1512267, 1512278, 1512289, 1512469, 1512481, 1512504, 1512515, 1512593, 1512605
ES	Centro de información online de medicamentos de la AEMPS	033178359, 033178942, 64454, 64473, 68817, 72385
FI	Lääkealan turvallisuus- ja kehittämiskeskus	005910, 005932, 005954, 005976, 018670, 025455, 093343
GB	Medicines & Healthcare Products Regulatory Agency	200018
HK	Department of Health Drug Office	49137, 49138, 59452, 59453, 59454, 60033
HR	Agencija za lijekove i medicinske proizvode	HR-H-807143753
IE	Health Products Regulatory Authority	73702, 73708, 73712, 73713, 73728, 73755, 73762, 73766, 73770, 73775
IL	מִשְׂרַד הַבְּרִיאוּת	3631, 3632, 6097
JP	医薬品医療機器総合機構	2149041F1020, 2149041F2027, 2149041F3023, 2149041F4020, 2149041F5026, 2149041F6022, 2149041F7029, 2149041F8025
LT	Valstybinė vaistų kontrolės tarnyba	1004288, 1004289, 1005004, 1022020, 1033369, 1033370, 1033371, 1033373, 1033374, 1033375, 1054248, 1060237, 1060238, 1060239, 1060240, 1060241, 1060242, 1060243, 1060244, 1060245, 1060246, 1060247, 1060248, 1060249, 1060250, 1060251, 1060252, 1060253, 1060254, 1060255, 1060256, 1060257, 1060258, 1060259, 1060260, 1060261, 1060262, 1060263, 1060264, 1060274, 1060275, 1060276, 1060277, 1060278, 1060279, 1060280
MT	Medicines Authority	MA1249/02101, MA1249/02102, MA1249/02103, MA1249/02104, MA1249/02105, PI1438/02401A, PI1438/02402A, PI521/08001B, PI521/08002A, PI908/05002A, PI908/05003A, PI908/05004A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	013M2002
NG	Registered Drug Product Database	04-2100, A4-0017, B4-2584
NL	Z-Index G-Standaard, PRK	61220, 61239, 82821, 94188
NZ	Medicines and Medical Devices Safety Authority	10321, 12214, 9919, 9920
PL	Rejestru Produktów Leczniczych	100107195, 100107203, 100229886
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W55631001, W56929001, W56929002, W56929003, W56929004, W56929005, W56929006, W56929007, W56929008, W56929009, W56929010, W56929011, W56929012, W56929013, W56929014, W56929015, W56929016, W56929017, W56929018, W56929019, W56929020, W56929021, W56929022, W56929023, W56929024, W56929025, W56929026, W56929027, W56929028, W56929029, W56929030, W56930001, W56930002, W56930003, W56930005, W56930006, W56930007, W56930008, W56930009, W56930010, W56930011, W56930012, W56930013, W56930014, W56930015, W56930016, W56930017, W56930018, W56930019, W56930020, W56930021, W56930022, W56930023, W56930024, W56930025, W56930026, W56930027, W56930028, W56930029, W56930030, W56930031, W56931001, W56931002, W56931003, W56931004, W56931005, W56931006, W56931007, W56931008, W56931009, W56931010, W56931011, W56931012, W56931013, W56931014, W56931015, W56931016, W56931017, W56931018, W56931019, W56931020, W56931021, W56931022, W56931023, W56931024, W56931025, W56931026, W56931027, W56931028, W56931029, W56931030
SG	Health Sciences Authority	11554P, 11555P, 13101P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504090703, 8699504090758, 8699504091113, 8699504091953, 8699504091960
US	FDA, National Drug Code	0078-0358, 0078-0359, 0078-0360, 0078-0423, 55289-817, 55289-825, 55289-876
ZA	Health Products Regulatory Authority	31/7.1.3/0100, 31/7.1.3/0101, 36/7.1.3/0034, 36/7.1.3/0035, 36/7.1.3/0382, A40/7.1.3/0542